The big risk facing Slater & Gordon Limited shares

Slater & Gordon Limited (ASX:SGH) shares are trading for roughly 25 cents, giving them a market value less than $90 million.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of Slater & Gordon Limited (ASX: SGH) are feeling the pinch again today, sliding 3.1% after a brief rebound on Thursday.

The embattled law firm's share price has sunk to just 25.2 cents, giving the company a market value of just under $89 million. It was valued at more than $2 billion roughly 12 months ago when the shares briefly traded for more than $8 each.

One-year chart; Source: ASX
One-year chart; Source: ASX

Indeed, it has been all downhill since then. Just last week the company announced the resignation of Ms Moana Weir, Group General Counsel and Company Secretary after spending less than two months in the job.

It seems likely that her decision was due to the stresses involved in the role even during that short period, with the company dealing with a major write-down related to its recent Quindell PLC acquisition and the prospect of various shareholder class actions.

In addition, the company is also at the mercy of its banking syndicate, comprised of National Australia Bank Ltd. (ASX: NAB) and Westpac Banking Corp (ASX: WBC). Slater & Gordon is to meet with its syndicate in the hope of securing new loan terms but, if an agreement is not reached by the end of the month, it could be forced to repay its bank loans in their entirety by 31 March, 2017.

The risk facing the business is very clear. As at 31 December, 2015, the bank had drawings of $783 million under the syndicated debt facility. That compares to just under $52 million of cash, a total of $664 million in current liabilities ($4 million of which is classified as short term borrowings) and total cash flows from operations of just $40.8 million during the 2015 financial year (ended 30 June, 2015).

Things aren't looking good for Slater & Gordon's shares. Even if the company can rearrange a new deal with its financiers, it's still a very risky bet and one that Foolish investors should avoid.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »